Development, Calibration and Performance of an HIV Transmission Model Incorporating Natural History and Behavioral Patterns: Application in South Africa
Understanding HIV transmission dynamics is critical to estimating the potential population-wide impact of HIV prevention and treatment interventions. We developed an individual-based simulation model of the heterosexual HIV epidemic in South Africa and linked it to the previously published Cost-Effectiveness of Preventing AIDS Complications (CEPAC) International Model, which simulates the natural history and treatment of HIV. In this new model, the CEPAC Dynamic Model (CDM), the probability of HIV transmission per sexual encounter between short-term, long-term and commercial sex worker partners depends upon the HIV RNA and disease stage of the infected partner, condom use, and the circumcision status of the uninfected male partner. We included behavioral, demographic and biological values in the CDM and calibrated to HIV prevalence in South Africa pre-antiretroviral therapy. Using a multi-step fitting procedure based on Bayesian melding methodology, we performed 264,225 simulations of the HIV epidemic in South Africa and identified 3,750 parameter sets that created an epidemic and had behavioral characteristics representative of a South African population pre-ART. Of these parameter sets, 564 contributed 90% of the likelihood weight to the fit, and closely reproduced the UNAIDS HIV prevalence curve in South Africa from 1990–2002. The calibration was sensitive to changes in the rate of formation of short-duration partnerships and to the partnership acquisition rate among high-risk individuals, both of which impacted concurrency. Runs that closely fit to historical HIV prevalence reflect diverse ranges for individual parameter values and predict a wide range of possible steady-state prevalence in the absence of interventions, illustrating the value of the calibration procedure and utility of the model for evaluating interventions. This model, which includes detailed behavioral patterns and HIV natural history, closely fits HIV prevalence estimates.
References
[1]
UNAIDS (2012) AIDSinfo Online Database - South Africa.
[2]
UNAIDS/WHO (2009) AIDS Epidemic Update: November 2009. Geneva: UNAIDS.
[3]
Abuelezam NN, Rough K, Seage III GR (2013) Individual-based simulation models of HIV transmission: reporting quality and recommendations. PLOS ONE: DOI: 10.1371/journal.pone.0075624
[4]
Hontelez JA, Lurie MN, Barnighausen T, Bakker R, Baltussen R, et al. (2013) Elimination of HIV in South Africa through Expanded Access to Antiretroviral Therapy: A Model Comparison Study. PLOS Medicine 10: e1001534. doi: 10.1371/journal.pmed.1001534
[5]
Wallinga J, Lipsitch M (2007) How generation intervals shape the relationship between growth rates and reproductive numbers. Proceedings Biological Sciences 274: 599–604. doi: 10.1098/rspb.2006.3754
[6]
McCormick AW, Walensky RP, Lipsitch M, Losina E, Hsu H, et al. (2007) The effect of antiretroviral therapy on secondary transmission of HIV among men who have sex with men. Clinical Infectious Diseases 44: 1115–1122. doi: 10.1086/512816
[7]
Jacquez JA, Koopman JS, Simon CP, Longini IM Jr (1994) Role of the primary infection in epidemics of HIV infection in gay cohorts. Journal of Acquired Immune Deficiency Syndromes 7: 1169–1184. doi: 10.1097/00042560-199505010-00020
[8]
Garnett GP, Anderson RM (1993) Factors controlling the spread of HIV in heterosexual communities in developing countries: patterns of mixing between different age and sexual activity classes. Philosophical Transactions of the Royal Society B: Biological Sciences 342: 137–159. doi: 10.1098/rstb.1993.0143
[9]
Garnett GP, Anderson RM (1994) Balancing sexual partnerships in an age and activity stratified model of HIV transmission in heterosexual populations. IMA Journal of Mathematics Applied in Medicine and Biology 11: 161–192. doi: 10.1093/imammb/11.3.161
[10]
Doherty IA, Schoenbach VJ, Adimora AA (2009) Sexual mixing patterns and heterosexual HIV transmission among African Americans in the southeastern United States. Journal of Acquired Immune Deficiency Syndromes 52: 114–120. doi: 10.1097/qai.0b013e3181ab5e10
[11]
Barlow D, Daker-White G, Band B (1997) Assortative sexual mixing in a heterosexual clinic population–a limiting factor in HIV spread? AIDS 11: 1039–1044. doi: 10.1097/00002030-199708000-00013
[12]
Morris M, Kretzschmar M (1995) Concurrent partnerships and transmission dynamics in networks. Social Networks 17: 299–318. doi: 10.1016/0378-8733(95)00268-s
[13]
Mah TL, Halperin DT (2010) Concurrent sexual partnerships and the HIV epidemics in Africa: evidence to move forward. AIDS and Behavior 14: 11–16; dicussion 34–17. doi: 10.1007/s10461-008-9433-x
[14]
Eaton JW, Hallett TB, Garnett GP (2011) Concurrent sexual partnerships and primary HIV infection: a critical interaction. AIDS and Behavior 15: 687–692. doi: 10.1007/s10461-010-9787-8
[15]
Hontelez JA, Nagelkerke N, Barnighausen T, Bakker R, Tanser F, et al. (2011) The potential impact of RV144-like vaccines in rural South Africa: a study using the STDSIM microsimulation model. Vaccine 29: 6100–6106. doi: 10.1016/j.vaccine.2011.06.059
[16]
Bendavid E, Brandeau ML, Wood R, Owens DK (2010) Comparative effectiveness of HIV testing and treatment in highly endemic regions. Archives of Internal Medicine 170: 1347–1354. doi: 10.1001/archinternmed.2010.249
[17]
Hallett TB, Baeten JM, Heffron R, Barnabas R, de Bruyn G, et al. (2011) Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study. PLOS Medicine 8: e1001123. doi: 10.1371/journal.pmed.1001123
[18]
Hoare A, Gray RT, Wilson DP (2012) Could implementation of Australia's national gay men's syphilis action plan have an indirect effect on the HIV epidemic? Sexual Health 9: 144–151. doi: 10.1071/sh10145
[19]
McCreesh N, O'Brien K, Nsubuga RN, Shafer LA, Bakker R, et al. (2012) Exploring the potential impact of a reduction in partnership concurrency on HIV incidence in rural Uganda: a modeling study. Sexually Transmitted Diseases 39: 407–413. doi: 10.1097/olq.0b013e318254c84a
[20]
Eaton JW, Menzies NA, Stover J, Cambiano V, Chindelevitch L, et al. (2014) Health benefits, cost, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models. The Lancet Global Health 2: e23–234. doi: 10.1016/s2214-109x(13)70172-4
[21]
Cambiano V, Bertagnolio S, Jordan MR, Lundgren JD, Phillips A (2013) Transmission of drug resistant HIV and its potential impact on mortality and treatment outcomes in resource-limited settings. Journal of Infectious Diseases 207 Suppl 2S57–62. doi: 10.1093/infdis/jit111
[22]
Bershteyn A, Klein DJ, Eckhoff PA (2013) Age-dependent partnering and the HIV transmission chain: a microsimulation analysis. Journal of the Royal Society Interface 10: 20130613. doi: 10.1098/rsif.2013.0613
[23]
Levin BR, Bull JJ, Stewart FM (1996) The intrinsic rate of increase of HIV/AIDS: epidemiological and evolutionary implications. Mathematical Biosciences 132: 69–96. doi: 10.1016/0025-5564(95)00053-4
[24]
Garnett GP, Anderson RM (1996) Sexually transmitted diseases and sexual behavior: insights from mathematical models. The Journal of Infectious Diseases 174: S150–161. doi: 10.1093/infdis/174.supplement_2.s150
[25]
Poole D, Raftery AE (2000) Inference for deterministic simulation models: the Bayesian melding approach. Journal of the American Statistical Association 95: 1244–1255. doi: 10.1080/01621459.2000.10474324
[26]
Alkema L, Raftery AE, Brown T (2008) Bayesian melding for estimating uncertainty in national HIV prevalence estimates. Sexually Transmitted Infections 84: i11–i16. doi: 10.1136/sti.2008.029991
[27]
Alkema L, Raftery AE, Clark SJ (2007) Probabilistic projections of HIV prevalence using Bayesian melding. The Annals of Applied Statistics 1: 229–248. doi: 10.1214/07-aoas111
[28]
Johnson LF, Alkema L, Dorrington RE (2010) A Bayesian approach to uncertainty analysis of sexually transmitted infection models. Sexually Transmitted Infections 86: 169–174. doi: 10.1136/sti.2009.037341
[29]
Raftery AE, Bao L (2010) Estimating and Projecting Trends in HIV/AIDS Generalized Epidemics Using Incremental Mixture Importance Sampling. Biometrics 66: 1162–1173. doi: 10.1111/j.1541-0420.2010.01399.x
[30]
Goldie SJ, Yazdanpanah Y, Losina E, Weinstein MC, Anglaret X, et al. (2006) Cost-effectiveness of HIV treatment in resource-poor settings–the case of C？te d'Ivoire. The New England Journal of Medicine 355: 1141–1153. doi: 10.1056/nejmsa060247
[31]
Walensky RP, Wood R, Fofana MO, Martinson NA, Losina E, et al. (2011) The clinical impact and cost-effectiveness of routine, voluntary HIV screening in South Africa. Journal of Acquired Immune Deficiency Syndromes 56: 26–35. doi: 10.1097/qai.0b013e3181fb8f24
[32]
Walensky RP, Wood R, Ciaranello AL, Paltiel AD, Lorenzana SB, et al. (2010) Scaling up the 2010 World Health Organization HIV Treatment Guidelines in resource-limited settings: a model-based analysis. PLOS Medicine 7: e1000382. doi: 10.1371/journal.pmed.1000382
[33]
Walensky RP, Wolf LL, Wood R, Fofana MO, Freedberg KA, et al. (2009) When to start antiretroviral therapy in resource-limited settings. Annals of Internal Medicine 151: 157–166. doi: 10.7326/0003-4819-151-3-200908040-00138
[34]
Yazdanpanah Y, Losina E, Anglaret X, Goldie SJ, Walensky RP, et al. (2005) Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in C？te d'Ivoire: a trial-based analysis. AIDS 19: 1299–1308. doi: 10.1097/01.aids.0000180101.80888.c6
[35]
The CEPAC Team (2014) CEPAC, Cost-Effectiveness of Preventing AIDS Complications, Available: http://web2.research.partners.org.
[36]
Mellors JW, Mu？oz A, Giorgi JV, Margolick JB, Tassoni CJ, et al. (1997) Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Annals of Internal Medicine 126: 946–954. doi: 10.7326/0003-4819-126-12-199706150-00003
[37]
Holmes CB, Wood R, Badri M, Zilber S, Wang B, et al. (2006) CD4 decline and incidence of opportunistic infections in Cape Town, South Africa: implications for prophylaxis and treatment. Journal of Acquired Immune Deficiency Syndromes 42: 464–469. doi: 10.1097/01.qai.0000225729.79610.b7
[38]
U.S Census Bureau (2012) International Data Base Demographic Overview for South Africa.
[39]
Pettifor AE, Rees HV, Kleinschmidt I, Steffenson AE, MacPhail C, et al. (2005) Young people's sexual health in South Africa: HIV prevalence and sexual behaviors from a nationally representative household survey. AIDS 19: 1525–1534. doi: 10.1097/01.aids.0000183129.16830.06
[40]
Shisana O, Simbayi LC (2002) Nelson Mandela/HSRC Study of HIV/AIDS: South African National HIV Prevalence, Behavioural Risks and Mass Media: Household Survey 2002. Cape Town: Human Sciences Research Council Publishers.
[41]
Department of Health (2002) South Africa Demographic and Health Survey 1998 - Full Report.
[42]
Lopez AD, Ahmad OB, Guillot M, Ferguson BD, Salomon JA, et al.. (2002) World mortality in 2000: life tables for 191 countries. Geneva: World Health Organization.
[43]
Losina E, Yazdanpanah Y, Deuffic-Burban S, Wang B, Wolf LL, et al. (2007) The independent effect of highly active antiretroviral therapy on severe opportunistic disease incidence and mortality in HIV-infected adults in Cote d'Ivoire. Antiviral Therapy 12: 543–551.
[44]
Losina E, Anglaret X, Yazdanpanah Y, Wang B, Toure S, et al. (2006) Impact of opportunistic diseases on chronic mortality in HIV-infected adults in Cote d'Ivoire. South African Medical Journal 96: 526–529.
[45]
Walensky RP, Park JE, Wood R, Freedberg KA, Scott CA, et al. (2012) The cost-effectiveness of pre-exposure prophylaxis for HIV infection in South African women. Clinical Infectious Diseases 54: 1504–1513. doi: 10.1093/cid/cis225
[46]
Williams BG, Korenromp EL, Gouws E, Schmid GP, Auvert B, et al. (2006) HIV infection, antiretroviral therapy, and CD4+ cell count distributions in African populations. The Journal of Infectious Diseases 194: 1450–1458. doi: 10.1086/508206
[47]
Lawrie D, Coetzee LM, Becker P, Mahlangu J, Stevens W, et al. (2009) Local reference ranges for full blood count and CD4 lymphocyte count testing. S Afr Med J 99: 243–248.
[48]
Korenromp EL, Williams BG, Schmid GP, Dye C (2009) Clinical prognostic value of RNA viral load and CD4 cell counts during untreated HIV-1 infection—a quantitative review. PLOS ONE 4: e5950. doi: 10.1371/journal.pone.0005950
[49]
Maini MK, Gilson RJ, Chavda N, Gill S, Fakoya A, et al. (1996) Reference ranges and sources of variability of CD4 counts in HIV-seronegative women and men. Genitourinary Medicine 72: 27–31. doi: 10.1136/sti.72.1.27
[50]
U.S. Preventive Services Task Force (2005) Screening for HIV: recommendation statement. Annals of Internal Medicine 143: 32–37. doi: 10.7326/0003-4819-159-5-201309030-00677
[51]
Centers for Disease Control and Prevention (2006) Epidemiology of HIV/AIDS –United States, 1981–2005. Morbidity and Mortality Weekly Report 55: 589–592.
[52]
World Health Organization (2006) Antiretroviral therapy for HIV infection in adults and adolescents: Recommendations for a public health approach - 2006 Revision. Geneva: World Health Organization.
[53]
Detsky AS (1993) Guidelines for economic analysis of pharmaceutical products. PharmacoEconomics 3: 354–361. doi: 10.2165/00019053-199303050-00003
[54]
Branson BM, Handsfield HH, Lampe MA, Janssen RS, Taylor AW, et al. (2006) Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. Morbidity and Mortality Weekly Report 55: 1–17.
[55]
Chou R, Huffman L (2007) Screening for HIV: Focused Update of a 2005 Systematic Evidence Review for the U.S. Preventive Services Task Force.
[56]
Baxter JD, Mayers DL, Wentworth DN, Neaton JD, Hoover ML, et al. (2000) A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDS. Aids 14: F83–93. doi: 10.1097/00002030-200006160-00001
[57]
Introcaso CE, Xu F, Kilmarx PH, Zaidi A, Markowitz LE (2013) Prevalence of circumcision among men and boys aged 14 to 59 years in the United States, National Health and Nutrition Examination Surveys 2005–2010. Sexually Transmitted Diseases 40: 521–525. doi: 10.1097/01.olq.0000430797.56499.0d
[58]
Ricard D, Wilkins A, N'Gum PT, Hayes R, Morgan G, et al. (1994) The effects of HIV-2 infection in a rural area of Guinea-Bissau. AIDS 8: 977–982. doi: 10.1097/00002030-199407000-00016
[59]
Lara AM, Wakholi BN, Kasirye A, Munderi P, Watera C, et al. (2008) Utility assessment of HIV/AIDS-related health states in HIV-infected Ugandans. AIDS 22 Suppl 1S123–130. doi: 10.1097/01.aids.0000327633.85221.9a
[60]
Kelly R, Kiwanuka N, Wawer MJ, Serwadda D, Sewankambo NK, et al. (1999) Age of male circumcision and risk of prevalent HIV infection in rural Uganda. AIDS 13: 399–405. doi: 10.1097/00002030-199902250-00013
[61]
Phair JP, Margolick JB, Jacobson LP, Phillips J, Rinaldo C, et al. (1997) Detection of infection with human immunodeficiency virus type 1 before seroconversion: correlation with clinical symptoms and outcome. The Journal of Infectious Diseases 175: 959–962. doi: 10.1086/514000
[62]
Urassa W, Bakari M, Sandstrom E, Swai A, Pallangyo K, et al. (2004) Rate of decline of absolute number and percentage of CD4 T lymphocytes among HIV-1-infected adults in Dar es Salaam, Tanzania. AIDS 18: 433–438. doi: 10.1097/00002030-200402200-00009
[63]
Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG (2009) Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. The Lancet 373: 48–57. doi: 10.1016/s0140-6736(08)61697-9
[64]
World Health Organization (2010) Life expectancy: Life tables South Africa.
[65]
Gray RH, Wawer MJ, Brookmeyer R, Sewankambo NK, Serwadda D, et al. (2001) Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. The Lancet 357: 1149–1153. doi: 10.1016/s0140-6736(00)04331-2
[66]
Wawer MJ, Gray RH, Sewankambo NK, Serwadda D, Li X, et al. (2005) Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. The Journal of Infectious Diseases 191: 1403–1409. doi: 10.1086/429411
[67]
Boily MC, Baggaley RF, Wang L, Masse B, White RG, et al. (2009) Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. The Lancet Infectious Diseases 9: 118–129. doi: 10.1016/s1473-3099(09)70021-0
[68]
Powers KA, Poole C, Pettifor AE, Cohen MS (2008) Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis. The Lancet Infectious Diseases 8: 553–563. doi: 10.1016/s1473-3099(08)70156-7
[69]
？ev？íková H, Raftery AE, Waddell PA (2007) Assessing uncertainty in urban simulations using Bayesian melding. Transportation Research Part B: Methodological 41: 652–669. doi: 10.1016/j.trb.2006.11.001
[70]
UNAIDS (2010) Global Report: UNAIDS report on the global AIDS epidemic 2010.
[71]
Blower S, Dowlatabadi H (1994) Sensitivity and uncertainty analysis of complex models of disease transmission: an HIV model, as an example. International Statistical Review 62: 229–243. doi: 10.2307/1403510
[72]
Raftery AE, Givens GH, Zeh JE (1995) Inference from a deterministic population dynamics model for bowhead whales. Journal of the American Statistical Association 90: 402–416. doi: 10.1080/01621459.1995.10476529
[73]
Gibson GJ, Kleczkowski A, Gilligan CA (2004) Bayesian analysis of botanical epidemics using stochastic compartmental models. Proceedings of the National Academy of Sciences of the United States of America 101: 12120–12124. doi: 10.1073/pnas.0400829101
[74]
Eisenberg JN, Brookhart MA, Rice G, Brown M, Colford JM Jr (2002) Disease transmission models for public health decision making: analysis of epidemic and endemic conditions caused by waterborne pathogens. Environmental Health Perspectives 110: 783–790. doi: 10.1289/ehp.02110783
[75]
Wu JT, Leung GM, Lipsitch M, Cooper BS, Riley S (2009) Hedging against antiviral resistance during the next influenza pandemic using small stockpiles of an alternative chemotherapy. PLOS Medicine 6: e1000085. doi: 10.1371/journal.pmed.1000085
[76]
Blower SM, Aschenbach AN, Gershengorn HB, Kahn JO (2001) Predicting the unpredictable: transmission of drug-resistant HIV. Nature Medicine 7: 1016–1020. doi: 10.1038/nm0103-146a
[77]
Gray RH, Li X, Wawer MJ, Gange SJ, Serwadda D, et al. (2003) Stochastic simulation of the impact of antiretroviral therapy and HIV vaccines on HIV transmission; Rakai, Uganda. AIDS 17: 1941–1951. doi: 10.1097/00002030-200309050-00013
[78]
Stover J, Walker N, Garnett GP, Salomon JA, Stanecki KA, et al. (2002) Can we reverse the HIV/AIDS pandemic with an expanded response? The Lancet 360: 73–77. doi: 10.1016/s0140-6736(02)09339-x
[79]
Baggaley RF, Garnett GP, Ferguson NM (2006) Modelling the impact of antiretroviral use in resource-poor settings. PLOS Medicine 3: e124. doi: 10.1371/journal.pmed.0030124
[80]
Abbas UL, Anderson RM, Mellors JW (2007) Potential impact of antiretroviral chemoprophylaxis on HIV-1 transmission in resource-limited settings. PLOS ONE 2: e875. doi: 10.1371/journal.pone.0000875
[81]
Abbas UL, Anderson RM, Mellors JW (2006) Potential impact of antiretroviral therapy on HIV-1 transmission and AIDS mortality in resource-limited settings. Journal of Acquired Immune Deficiency Syndromes 41: 632–641. doi: 10.1097/01.qai.0000194234.31078.bf
[82]
Auvert B, Buonamico G, Lagarde E, Williams B (2000) Sexual behavior, heterosexual transmission, and the spread of HIV in sub-Saharan Africa: a simulation study. Computers and Biomedical Research 33: 84–96. doi: 10.1006/cbmr.1999.1533
[83]
Hallett TB, Singh K, Smith JA, White RG, Abu-Raddad LJ, et al. (2008) Understanding the impact of male circumcision interventions on the spread of HIV in southern Africa. PLOS ONE 3: e2212. doi: 10.1371/journal.pone.0002212
[84]
Stover J, Bollinger L, Cooper-Arnold K (2003) Goals model for estimating the effects of resource allocation decisions on the achievement of the goals of the HIV/AIDS strategic plan (version 3.0). Glastonbury, Connecticut and Washington: The Futures Group International.
[85]
Vieira IT, Cheng R, Harper PR, de Senna V (2010) Small world network models of the dynamics of HIV infection. Annals of Operations Research 178: 173–200. doi: 10.1007/s10479-009-0571-y
[86]
Walensky RP, Paltiel AD, Losina E, Morris BL, Scott CA, et al. (2010) Test and treat DC: forecasting the impact of a comprehensive HIV strategy in Washington DC. Clin Infect Dis 51: 392–400. doi: 10.1086/655130
[87]
UNAIDS (2012) A progress report on the Global Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive.
[88]
Patel K, Hernan MA, Williams PL, Seeger JD, McIntosh K, et al. (2008) Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study. Clinical Infectious Diseases 46: 507–515. doi: 10.1086/526524
[89]
Edmonds A, Yotebieng M, Lusiama J, Matumona Y, Kitetele F, et al. (2011) The effect of highly active antiretroviral therapy on the survival of HIV-infected children in a resource-deprived setting: a cohort study. PLOS Medicine 8: e1001044. doi: 10.1371/journal.pmed.1001044
[90]
Tassiopoulos K, Moscicki AB, Mellins C, Kacanek D, Malee K, et al. (2013) Sexual risk behavior among youth with perinatal HIV infection in the United States: predictors and implications for intervention development. Clinical Infectious Diseases 56: 283–290. doi: 10.1093/cid/cis816
[91]
Vandepitte J, Lyerla R, Dallabetta G, Crabbe F, Alary M, et al. (2006) Estimates of the number of female sex workers in different regions of the world. Sexually Transmitted Infections 82: iii18–25. doi: 10.1136/sti.2006.020081
[92]
Shisana O, Rehle T, Simbayi L, Parker W, Zuma K, et al.. (2005) South African national HIV prevalence, HIV incidence, behaviour and communication survery, 2005. Cape Town: HSRC Press.
[93]
Meekers D (2000) Going underground and going after women: trends in sexual risk behaviour among gold miners in South Africa. International Journal of STD and AIDS 11: 21–26. doi: 10.1258/0956462001914850
[94]
Dunkle KL, Beksinska ME, Rees VH, Ballard RC, Htun Y, et al. (2005) Risk factors for HIV infection among sex workers in Johannesburg, South Africa. International Journal of STD and AIDS 16: 256–261. doi: 10.1258/0956462053420220
[95]
Carael M, Slaymaker E, Lyerla R, Sarkar S (2006) Clients of sex workers in different regions of the world: hard to count. Sexually Transmitted Infections 82: iii26–33. doi: 10.1136/sti.2006.021196
[96]
Johnson L, Dorrington R, Bradshaw D, Pillay-Van Wyk V, Rehle T (2009) Sexual behaviour patterns in South Africa and their association with the spread of HIV: Insights from a mathematical model. Demographic Research 21: 289–340. doi: 10.4054/demres.2009.21.11
[97]
Padian NS, van der Straten A, Ramjee G, Chipato T, de Bruyn G, et al. (2007) Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. The Lancet 370: 251–261. doi: 10.1016/s0140-6736(07)60950-7
[98]
Zuma K, Lurie MN, Williams BG, Mkaya-Mwamburi D, Garnett GP, et al. (2005) Risk factors of sexually transmitted infections among migrant and non-migrant sexual partnerships from rural South Africa. Epidemiology and Infection 133: 421–428. doi: 10.1017/s0950268804003607
[99]
Skoler-Karpoff S, Ramjee G, Ahmed K, Altini L, Plagianos MG, et al. (2008) Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial. The Lancet 372: 1977–1987. doi: 10.1016/s0140-6736(08)61842-5
[100]
Jewkes R, Nduna M, Levin J, Jama N, Dunkle K, et al. (2006) A cluster randomized-controlled trial to determine the effectiveness of Stepping Stones in preventing HIV infections and promoting safer sexual behaviour amongst youth in the rural Eastern Cape, South Africa: trial design, methods and baseline findings. Tropical Medicine and International Health 11: 3–16. doi: 10.1111/j.1365-3156.2005.01530.x
[101]
Lurie MN, Williams BG, Zuma K, Mkaya-Mwamburi D, Garnett G, et al. (2003) The impact of migration on HIV-1 transmission in South Africa: a study of migrant and nonmigrant men and their partners. Sexually Transmitted Diseases 30: 149–156. doi: 10.1097/00007435-200302000-00011
[102]
Harrison A, Cleland J, Frohlich J (2008) Young people's sexual partnerships in KwaZulu-Natal, South Africa: patterns, contextual influences, and HIV risk. Studies in Family Planning 39: 295–308. doi: 10.1111/j.1728-4465.2008.00176.x
[103]
Chopra M, Townsend L, Johnston L, Mathews C, Tomlinson M, et al. (2009) Estimating HIV prevalence and risk behaviors among high-risk heterosexual men with multiple sex partners: use of respondent-driven sampling. Journal of Acquired Immune Deficiency Syndromes 51: 72–77. doi: 10.1097/qai.0b013e31819907de
[104]
Ndase P, Celum C, Thomas K, Donnell D, Fife KH, et al. (2012) Outside sexual partnerships and risk of HIV acquisition for HIV uninfected partners in African HIV serodiscordant partnerships. Journal of Acquired Immune Deficiency Syndromes 59: 65–71. doi: 10.1097/qai.0b013e318237b864
